SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC Keeping it real board for pro and con discussions
NNVC 1.220-3.2%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: donpat who wrote (10)12/22/2014 3:57:36 PM
From: Rawnoc   of 326
 
March 2009--NanoViricides, Inc. Signs Agreement with a Major Pharma

"It is the understanding of the Parties that, should the testing results be favorable, they will enter into good faith negotiations for a potential long-term, exclusive, worldwide licensing agreement for the development and commercialization of the drug."
businesswire.com

That was in 2009, and NNVC hasn't said a peep IN SEC FILINGS about it since. No wonder no other major pharma will touch this POS. I guess the testing results weren't too "favourable" eh?

November 2013 --"All of the major pharmas have approached me, but they said we're not going to come back until you do Phase 2a trials"
nbtequitiesresearch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext